Shopping Cart 0
Cart Subtotal
AED 0

Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Anavex Life Sciences Corp (AVXL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The company's target indications include Alzheimer's disease, Parkinson's disease, Rett syndrome, epilepsy, neuropathic pain, depression, prostate cancer, pancreatic cancer and malignant melanoma. Its pipeline comprises one drug candidate and several compounds in diverse stages of pre-clinical study. Anavex's lead compound ANAVEX 2-73 is being developed for the treatment of Alzheimer's disease, Parkinson's disease and potentially other CNS diseases, including rare diseases. Anavex is headquartered in New York, the US.

Anavex Life Sciences Corp Key Recent Developments

Feb 07,2019: Anavex Life Sciences reports fiscal 2019 first quarter financial results and provides clinical study updates

Jan 02,2019: Anavex Life Sciences names Walter E Kaufmann, MD as chief medical officer

Dec 12,2018: Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update

Dec 12,2018: Anavex Life Sciences reports fiscal year 2018 financial results and provides clinical study update

Oct 30,2018: First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson's Disease Dementia (PDD)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Anavex Life Sciences Corp-Key Facts

Anavex Life Sciences Corp-Key Employees

Anavex Life Sciences Corp-Key Employee Biographies

Anavex Life Sciences Corp-Major Products and Services

Anavex Life Sciences Corp-History

Anavex Life Sciences Corp-Company Statement

Anavex Life Sciences Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Anavex Life Sciences Corp-Business Description

R&D Overview

Anavex Life Sciences Corp-Corporate Strategy

Anavex Life Sciences Corp-SWOT Analysis

SWOT Analysis-Overview

Anavex Life Sciences Corp-Strengths

Anavex Life Sciences Corp-Weaknesses

Anavex Life Sciences Corp-Opportunities

Anavex Life Sciences Corp-Threats

Anavex Life Sciences Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Anavex Life Sciences Corp, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 07, 2019: Anavex Life Sciences reports fiscal 2019 first quarter financial results and provides clinical study updates

Jan 02, 2019: Anavex Life Sciences names Walter E Kaufmann, MD as chief medical officer

Dec 12, 2018: Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update

Dec 12, 2018: Anavex Life Sciences reports fiscal year 2018 financial results and provides clinical study update

Oct 30, 2018: First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson's Disease Dementia (PDD)

Oct 26, 2018: Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX2-73 in Alzheimer's Disease at the 2018 Clinical Trials on Alzheimer's Disease (CTAD) Meeting

Oct 19, 2018: Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX2-73 in Patients with Rett Syndrome

Aug 09, 2018: Anavex Life Sciences reports fiscal third quarter 2018 financial results

May 10, 2018: Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results

Mar 05, 2018: Anavex Life Sciences Announces Management Changes

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Anavex Life Sciences Corp, Performance Chart (2014-2018)

Anavex Life Sciences Corp, Ratio Charts

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Anavex Life Sciences Corp, Key Facts

Anavex Life Sciences Corp, Key Employees

Anavex Life Sciences Corp, Key Employee Biographies

Anavex Life Sciences Corp, Major Products and Services

Anavex Life Sciences Corp, History

Anavex Life Sciences Corp, Subsidiaries

Anavex Life Sciences Corp, Key Competitors

Anavex Life Sciences Corp, Ratios based on current share price

Anavex Life Sciences Corp, Annual Ratios

Anavex Life Sciences Corp, Annual Ratios (Cont...1)

Anavex Life Sciences Corp, Interim Ratios

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Anavex Life Sciences Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Anavex Life Sciences Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Perrigo Company Plc

Eli Lilly and Co

Allergan Plc

Pfizer Inc

GlaxoSmithKline Plc

Novartis AG

Merck & Co Inc

Axovant Sciences Ltd

Company Profile

Company Profile Title

Anavex Life Sciences Corp (AVXL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The company's target indications include Alzheimer's disease, Parkinson's disease, Rett syndrome, epilepsy, neuropathic pain, depression, prostate cancer, pancreatic cancer and malignant melanoma. Its pipeline comprises one drug candidate and several compounds in diverse stages of pre-clinical study. Anavex's lead compound ANAVEX 2-73 is being developed for the treatment of Alzheimer's disease, Parkinson's disease and potentially other CNS diseases, including rare diseases. Anavex is headquartered in New York, the US.

Anavex Life Sciences Corp Key Recent Developments

Feb 07,2019: Anavex Life Sciences reports fiscal 2019 first quarter financial results and provides clinical study updates

Jan 02,2019: Anavex Life Sciences names Walter E Kaufmann, MD as chief medical officer

Dec 12,2018: Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update

Dec 12,2018: Anavex Life Sciences reports fiscal year 2018 financial results and provides clinical study update

Oct 30,2018: First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson's Disease Dementia (PDD)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Anavex Life Sciences Corp-Key Facts

Anavex Life Sciences Corp-Key Employees

Anavex Life Sciences Corp-Key Employee Biographies

Anavex Life Sciences Corp-Major Products and Services

Anavex Life Sciences Corp-History

Anavex Life Sciences Corp-Company Statement

Anavex Life Sciences Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Anavex Life Sciences Corp-Business Description

R&D Overview

Anavex Life Sciences Corp-Corporate Strategy

Anavex Life Sciences Corp-SWOT Analysis

SWOT Analysis-Overview

Anavex Life Sciences Corp-Strengths

Anavex Life Sciences Corp-Weaknesses

Anavex Life Sciences Corp-Opportunities

Anavex Life Sciences Corp-Threats

Anavex Life Sciences Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Anavex Life Sciences Corp, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 07, 2019: Anavex Life Sciences reports fiscal 2019 first quarter financial results and provides clinical study updates

Jan 02, 2019: Anavex Life Sciences names Walter E Kaufmann, MD as chief medical officer

Dec 12, 2018: Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update

Dec 12, 2018: Anavex Life Sciences reports fiscal year 2018 financial results and provides clinical study update

Oct 30, 2018: First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson's Disease Dementia (PDD)

Oct 26, 2018: Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX2-73 in Alzheimer's Disease at the 2018 Clinical Trials on Alzheimer's Disease (CTAD) Meeting

Oct 19, 2018: Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX2-73 in Patients with Rett Syndrome

Aug 09, 2018: Anavex Life Sciences reports fiscal third quarter 2018 financial results

May 10, 2018: Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results

Mar 05, 2018: Anavex Life Sciences Announces Management Changes

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Anavex Life Sciences Corp, Performance Chart (2014-2018)

Anavex Life Sciences Corp, Ratio Charts

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Anavex Life Sciences Corp, Key Facts

Anavex Life Sciences Corp, Key Employees

Anavex Life Sciences Corp, Key Employee Biographies

Anavex Life Sciences Corp, Major Products and Services

Anavex Life Sciences Corp, History

Anavex Life Sciences Corp, Subsidiaries

Anavex Life Sciences Corp, Key Competitors

Anavex Life Sciences Corp, Ratios based on current share price

Anavex Life Sciences Corp, Annual Ratios

Anavex Life Sciences Corp, Annual Ratios (Cont...1)

Anavex Life Sciences Corp, Interim Ratios

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Anavex Life Sciences Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Anavex Life Sciences Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Perrigo Company Plc

Eli Lilly and Co

Allergan Plc

Pfizer Inc

GlaxoSmithKline Plc

Novartis AG

Merck & Co Inc

Axovant Sciences Ltd